Invention Publication
- Patent Title: ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
-
Application No.: US18157643Application Date: 2023-01-20
-
Publication No.: US20230303684A1Publication Date: 2023-09-28
- Inventor: Daniel Getts , Yuxiao Wang
- Applicant: Myeloid Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Myeloid Therapeutics, Inc.
- Current Assignee: Myeloid Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K14/735 ; A61P35/00
Abstract:
Compositions and methods for making and using engineered cells, such as, engineered myeloid cells that express a chimeric fusion protein that has a binding domain capable to binding surface molecules on target cells such as diseased cells.
Public/Granted literature
- US12030938B2 Engineered chimeric fusion protein compositions and methods of use thereof Public/Granted day:2024-07-09
Information query
